More importantly, it was found that gerberoside decreased SIRT1 expression, thereby attenuating the nuclear accumulation of β-catenin and subsequently inhibiting Wnt/β-catenin signaling, thus sensitizing cisplatin-resistant ovarian cancer cells to chemotherapy [64]. Here, SIRT1 is linked to ovarian carcinoma.